Male Hypogonadism Market Segmented By Testosterone Replacement Therapy, Gonadotropin Replacement Therapy in Topical Gels, Injectables, Transdermal Patches, Drug Type in Klinefelter's Syndrome, Pituitary Adenomas, Kallmann Syndrome Disease Type
Industry: Healthcare
Published Date: April-2018
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 170
Report ID: PMRREP22303
1. Global Economic Outlook
2. Global Male Hypogonadism Market - Executive Summary
2.1. Opportunity Analysis - Male Hypogonadism Market
3. Global Male Hypogonadism Market Overview
3.1. Introduction
3.1.1. Global Male Hypogonadism Market Taxonomy
3.1.2. Global Male Hypogonadism Market Definition
3.2. Global Male Hypogonadism Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Male Hypogonadism Market Y-o-Y Growth
3.3. Global Male Hypogonadism Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. PESTL Analysis
3.8. Product Life Cycle Analysis
3.9. Epidemiology
3.10. List of Distributors
3.11. Key Participants Market Presence (Intensity Map) By Region
4. Global Male Hypogonadism Market Analysis and Forecast 2012-2026
4.1. Global Male Hypogonadism Market Size and Forecast By Therapy , 2012-2026
4.1.1. Testosterone Replacement Therapy Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Gonadotropin Replacement Therapy Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.2. Global Male Hypogonadism Market Size and Forecast By Drug Type, 2012-2026
4.2.1. Topical Gels Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Injectables Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Transdermal Patches Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.2.4. Others Market Size and Forecast, 2012-2026
4.2.4.1. Revenue (US$ Mn) Comparison, By Region
4.2.4.2. Market Share Comparison, By Region
4.2.4.3. Y-o-Y growth Comparison, By Region
4.3. Global Male Hypogonadism Market Size and Forecast By Disease Type, 2012-2026
4.3.1. Klinefelter's Syndrome Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Pituitary Adenomas Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Kallmann Syndrome Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
4.3.4. Other Types Market Size and Forecast, 2012-2026
4.3.4.1. Revenue (US$ Mn) Comparison, By Region
4.3.4.2. Market Share Comparison, By Region
4.3.4.3. Y-o-Y growth Comparison, By Region
5. North America Male Hypogonadism Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Therapy
5.6. Revenue (US$ Mn) Comparison, By Drug Type
5.7. Revenue (US$ Mn) Comparison, By Disease Type
6. Latin America Male Hypogonadism Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Therapy
6.6. Revenue (US$ Mn) Comparison, By Drug Type
6.7. Revenue (US$ Mn) Comparison, By Disease Type
7. Europe Male Hypogonadism Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Therapy
7.6. Revenue (US$ Mn) Comparison, By Drug Type
7.7. Revenue (US$ Mn) Comparison, By Disease Type
8. Japan Male Hypogonadism Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Revenue (US$ Mn), 2012-2026
8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Therapy
8.6. Revenue (US$ Mn) Comparison, By Drug Type
8.7. Revenue (US$ Mn) Comparison, By Disease Type
9. APEJ Male Hypogonadism Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Therapy
9.6. Revenue (US$ Mn) Comparison, By Drug Type
9.7. Revenue (US$ Mn) Comparison, By Disease Type
10. MEA Male Hypogonadism Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Therapy
10.6. Revenue (US$ Mn) Comparison, By Drug Type
10.7. Revenue (US$ Mn) Comparison, By Disease Type
11. Global Male Hypogonadism Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
11.3.1. Endo International Plc
11.3.2. Eli Lilly and Company Ltd.
11.3.3. AbbVie, Inc.
11.3.4. Pfizer, Inc.
11.3.5. Merck KGaA
11.3.6. Allergan Plc
11.3.7. Sun Pharmaceutical Industries Limited
11.3.8. Ferring B.V.
11.4. Key takeaways - Male Hypogonadism Market
12. Research Methodology
13. Secondary and Primary Sources
14. Assumptions and Acronyms
15. Disclaimer
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
TABLE 1: Global Male Hypogonadism Market Value (US$ Mn), 2012-2017
TABLE 2: Global Male Hypogonadism Market Value (US$ Mn), 2018-2026
TABLE 3: Global Male Hypogonadism Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4: Global Testosterone Replacement Therapy Segment Value (US$ Mn), By Region 2012-2017
TABLE 5: Global Testosterone Replacement Therapy Segment Value (US$ Mn), By Region 2018-2026
TABLE 6: Global Testosterone Replacement Therapy Segment Market Share, By Region 2012-2017
TABLE 7: Global Testosterone Replacement Therapy Segment Market Share, By Region 2018-2026
TABLE 8: Global Testosterone Replacement Therapy Segment Y-o-Y, By Region 2017-2026
TABLE 9: Global Gonadotropin Replacement Therapy Segment Value (US$ Mn), By Region 2012-2017
TABLE 10: Global Gonadotropin Replacement Therapy Segment Value (US$ Mn), By Region 2018-2026
TABLE 11: Global Gonadotropin Replacement Therapy Segment Market Share, By Region 2012-2017
TABLE 12: Global Gonadotropin Replacement Therapy Segment Market Share, By Region 2018-2026
TABLE 13: Global Gonadotropin Replacement Therapy Segment Y-o-Y, By Region 2017-2026
TABLE 14: Global Topical Gels Segment Value (US$ Mn), By Region 2012-2017
TABLE 15: Global Topical Gels Segment Value (US$ Mn), By Region 2018-2026
TABLE 16: Global Topical Gels Segment Market Share, By Region 2012-2017
TABLE 17: Global Topical Gels Segment Market Share, By Region 2018-2026
TABLE 18: Global Topical Gels Segment Y-o-Y, By Region 2017-2026
TABLE 19: Global Injectables Segment Value (US$ Mn), By Region 2012-2017
TABLE 20: Global Injectables Segment Value (US$ Mn), By Region 2018-2026
TABLE 21: Global Injectables Segment Market Share, By Region 2012-2017
TABLE 22: Global Injectables Segment Market Share, By Region 2018-2026
TABLE 23: Global Injectables Segment Y-o-Y, By Region 2017-2026
TABLE 24: Global Transdermal Patches Segment Value (US$ Mn), By Region 2012-2017
TABLE 25: Global Transdermal Patches Segment Value (US$ Mn), By Region 2018-2026
TABLE 26: Global Transdermal Patches Segment Market Share, By Region 2012-2017
TABLE 27: Global Transdermal Patches Segment Market Share, By Region 2018-2026
TABLE 28: Global Transdermal Patches Segment Y-o-Y, By Region 2017-2026
TABLE 29: Global Others Segment Value (US$ Mn), By Region 2012-2017
TABLE 30: Global Others Segment Value (US$ Mn), By Region 2018-2026
TABLE 31: Global Others Segment Market Share, By Region 2012-2017
TABLE 32: Global Others Segment Market Share, By Region 2018-2026
TABLE 33: Global Others Segment Y-o-Y, By Region 2017-2026
TABLE 34: Global Klinefelter's Syndrome Segment Value (US$ Mn), By Region 2012-2017
TABLE 35: Global Klinefelter's Syndrome Segment Value (US$ Mn), By Region 2018-2026
TABLE 36: Global Klinefelter's Syndrome Segment Market Share, By Region 2012-2017
TABLE 37: Global Klinefelter's Syndrome Segment Market Share, By Region 2018-2026
TABLE 38: Global Klinefelter's Syndrome Segment Y-o-Y, By Region 2017-2026
TABLE 39: Global Pituitary Adenomas Segment Value (US$ Mn), By Region 2012-2017
TABLE 40: Global Pituitary Adenomas Segment Value (US$ Mn), By Region 2018-2026
TABLE 41: Global Pituitary Adenomas Segment Market Share, By Region 2012-2017
TABLE 42: Global Pituitary Adenomas Segment Market Share, By Region 2018-2026
TABLE 43: Global Pituitary Adenomas Segment Y-o-Y, By Region 2017-2026
TABLE 44: Global Kallmann Syndrome Segment Value (US$ Mn), By Region 2012-2017
TABLE 45: Global Kallmann Syndrome Segment Value (US$ Mn), By Region 2018-2026
TABLE 46: Global Kallmann Syndrome Segment Market Share, By Region 2012-2017
TABLE 47: Global Kallmann Syndrome Segment Market Share, By Region 2018-2026
TABLE 48: Global Kallmann Syndrome Segment Y-o-Y, By Region 2017-2026
TABLE 49: Global Other Types Segment Value (US$ Mn), By Region 2012-2017
TABLE 50: Global Other Types Segment Value (US$ Mn), By Region 2018-2026
TABLE 51: Global Other Types Segment Market Share, By Region 2012-2017
TABLE 52: Global Other Types Segment Market Share, By Region 2018-2026
TABLE 53: Global Other Types Segment Y-o-Y, By Region 2017-2026
TABLE 54: North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 55: North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 56: North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 57: North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 58: North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 59: North America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
TABLE 60: North America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
TABLE 61: North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
TABLE 62: North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
TABLE 63: North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 64: North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 65: North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
TABLE 66: North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
TABLE 67: Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 68: Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 69: Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 70: Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 71: Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 72: Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
TABLE 73: Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
TABLE 74: Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
TABLE 75: Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
TABLE 76: Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 77: Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 78: Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
TABLE 79: Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
TABLE 80: Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 81: Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 82: Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 83: Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 84: Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 85: Europe Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
TABLE 86: Europe Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
TABLE 87: Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
TABLE 88: Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
TABLE 89: Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 90: Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 91: Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
TABLE 92: Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
TABLE 93: Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 94: Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 95: Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 96: Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 97: Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 98: Japan Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
TABLE 99: Japan Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
TABLE 100: Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
TABLE 101: Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
TABLE 102: Japan Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 103: Japan Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 104: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
TABLE 105: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
TABLE 106: APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 107: APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 108: APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 109: APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 110: APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 111: APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
TABLE 112: APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
TABLE 113: APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
TABLE 114: APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
TABLE 115: APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 116: APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 117: APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
TABLE 118: APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
TABLE 119: MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 120: MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 121: MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 122: MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 123: MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 124: MEA Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
TABLE 125: MEA Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
TABLE 126: MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
TABLE 127: MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
TABLE 128: MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 129: MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 130: MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
TABLE 131: MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
FIG. 1: Global Male Hypogonadism Market Value (US$ Mn), 2012-2017
FIG. 2: Global Male Hypogonadism Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3: Global Male Hypogonadism Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4: Global Testosterone Replacement Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5: Global Testosterone Replacement Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6: Global Testosterone Replacement Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7: Global Gonadotropin Replacement Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8: Global Gonadotropin Replacement Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9: Global Gonadotropin Replacement Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10: Global Topical Gels Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11: Global Topical Gels Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12: Global Topical Gels Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13: Global Injectables Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14: Global Injectables Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15: Global Injectables Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16: Global Transdermal Patches Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17: Global Transdermal Patches Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18: Global Transdermal Patches Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19: Global Others Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20: Global Others Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21: Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22: Global Klinefelter's Syndrome Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23: Global Klinefelter's Syndrome Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24: Global Klinefelter's Syndrome Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25: Global Pituitary Adenomas Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26: Global Pituitary Adenomas Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27: Global Pituitary Adenomas Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28: Global Kallmann Syndrome Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29: Global Kallmann Syndrome Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30: Global Kallmann Syndrome Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31: Global Other Types Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32: Global Other Types Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33: Global Other Types Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34: North America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
FIG. 35: North America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
FIG. 36: North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
FIG. 37: North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
FIG. 38: North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 39: North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 40: North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
FIG. 41: North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
FIG. 42: Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
FIG. 43: Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
FIG. 44: Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
FIG. 45: Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
FIG. 46: Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 47: Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 48: Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
FIG. 49: Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
FIG. 50: Europe Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
FIG. 51: Europe Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
FIG. 52: Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
FIG. 53: Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
FIG. 54: Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 55: Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 56: Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
FIG. 57: Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
FIG. 58: Japan Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
FIG. 59: Japan Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
FIG. 60: Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
FIG. 61: Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
FIG. 62: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
FIG. 63: Japan Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 64: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
FIG. 65: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
FIG. 66: APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
FIG. 67: APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
FIG. 68: APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
FIG. 69: APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
FIG. 70: APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 71: APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 72: APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
FIG. 73: APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
FIG. 74: MEA Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
FIG. 75: MEA Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
FIG. 76: MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
FIG. 77: MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
FIG. 78: MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 79: MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 80: MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
FIG. 81: MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
